Here is the gap this post exists to close. In Deloitte’s March 2025 global survey, 82% of life science executives said they were satisfied with their customer engagement strategy. Only 28% of healthcare professionals agreed that those strategies meet their needs.
Your strategy is probably rated higher inside your building than outside it. That is not a criticism; it is the industry baseline, and it means “best practices” copied from a checklist are not enough.
This post grades HCP marketing best practices by the evidence behind them, with the digital work your team can actually run. It is part of our full HCP marketing guide.
An overview of HCP marketing best practices in 2026
The digital layer now carries weight it never carried before. Sales rep access keeps declining, and the same Deloitte survey shows why the old model strains: 34% of healthcare professionals say rep messages are not tailored to them, and 42% cite insufficient access to MSLs as their primary challenge.
That gap does not get closed by hiring more reps. It gets closed by the digital layer: the channels, content, pages, and follow-up your life science marketing team controls directly.
So the best practices that matter in 2026 are not a list of channels. They are six disciplines, each graded here by the strength of the evidence behind it.
Six HCP marketing best practices that hold up in 2026
Rank practices by evidence, not by how often they appear in agency decks. Each of the six below ends with the discipline that makes it work.
Build the channel mix on where HCPs actually are online
There is no universal channel mix. In IQVIA’s 2025 European channel survey, the share of healthcare professionals whose most preferred channel matches what they actually receive ranges from 43% in Germany and the UK to 67% in Italy. Preferences shift by market, specialty, and career stage.
The practice: plan the mix per segment. LinkedIn leads for high-intent campaigns, endemic platforms like Doximity, Sermo, and Medscape sit beside it, and Meta works as a top-of-funnel discovery layer. A documented channel strategy per segment beats a global template, and HCP social media campaigns built for each platform’s context beat one asset pushed everywhere.
Treat your website and landing pages as the conversion layer
Every euro spent on HCP media resolves on a page you control. The ranking articles on this keyword skip this entirely, which tells you how common the gap is.
The practice: one page per campaign goal, built for one action, with the claim, the evidence, and the next step visible without digging. If the website layer cannot convert a specialist in ninety seconds, the channel budget upstream of it is leaking.
Fix content use before content volume
Veeva’s analysis of over 600 million annual HCP interactions found that nearly 80% of approved content is rarely or never used, while content-supported engagement doubles treatment starts. A content library nobody uses is a cost center with an MLR stamp.
The practice: fewer, better-used assets. Modular MLR-cleared content built per channel and specialty, measured by utilization, not by volume approved.
Use approved email and retargeting to extend precision reach
The first click from LinkedIn or an endemic platform is the expensive one. Approved email and retargeting are how that investment keeps working: they re-engage the healthcare professionals who already showed interest, at a fraction of the original cost.
The practice: marketing automation with explicit contact rules. Frequency caps, suppression when someone converts or opts out, and one owner for contact pressure across email, media, and events. Discipline here is what separates follow-up from spam.
Personalize by digital behavior, not job title
A title tells you who someone is; behavior tells you where they are in their decision. Content interactions, webinar attendance, and site behavior layered on top of specialty change the next message, not just the next audience.
The practice: personalize the decision, not the greeting. Topic, evidence depth, format, and timing adapt to what the healthcare professional actually did, within a lawful basis for every data point.
Measure campaigns by effect, not preference
Preference surveys tell you what HCPs say; platform dashboards tell you what happened near your campaign; neither proves what your campaign caused. IQVIA itself distinguishes stated preference from actual use and commercial impact.
The practice: set the baseline before launch, keep a holdout where feasible, and report metrics your CFO respects: cost per qualified lead, specialty-match rate, content utilization, pipeline contribution across the full journey. Impressions are an input, never an outcome.
The compliance layer around HCP marketing best practices
Enforcement went digital in 2025, and it reads everything. Three realities shape what your team publishes.
US enforcement now covers every digital surface
On September 9, 2025, the FDA announced thousands of warning letters and approximately 100 cease-and-desist letters over deceptive drug advertising. The reach is personal too: a May 2025 warning letter cited a chief executive’s own Instagram post for communicating benefits with no risk information. Branded search, landing pages, social posts, and executive accounts all count as promotion when they promote.
In the EU, there is no central clearance to hide behind
The EMA does not pre-clear or enforce medicine advertising; oversight sits with national authorities and codes. Language, required information, and hospitality rules differ by country.
An EU campaign is a set of national campaigns. Plan HCP verification, local prescribing information, and country-level review from day one, not after the creative is finished.
Social and influencer content is under the microscope
A 2025 peer-reviewed JAMA analysis of high-engagement drug posts found 80.1% qualified as potential undisclosed influencer promotion, with efficacy claims in 69% of posts but risk information in only a third. If your best practices include creators or KOL voices, disclosure and fair balance travel with them.
How to apply HCP marketing best practices in a lean team
Start where one discipline fixes your biggest leak. The starting point differs by industry.
For pharma teams, run one specialty segment through a complete digital journey: channel, page, content, follow-up, measured end to end. For biotech teams, build a concentrated digital program around the few centers and specialists who will decide the launch, and start collecting consent and first-party engagement now, before commercial scale-up. For medtech teams, go account-based: one product line, the buying group around the procedure, and content for each role in it.
Then run ninety days like an experiment. One segment. A baseline recorded before launch. One utilization or conversion metric that decides what scales. That cadence turns “best practices” from a listicle into an operating habit.
Picture the alternative: five channels live, a library of unused PDFs, and a quarterly report built on impressions. That is the 82/28 gap from the top of this post, reproduced in miniature.
This is the discipline HCP Compass marketers bring to client programs: segment-level channel plans, MLR-cleared content built to be used, automation that routes verified engagement into your CRM, and measurement designed before the first asset ships. Best practices are not what you know. They are what your next campaign actually does.
